Shareholder T. Rowe Price urges Allergan to hold off on deals
September 26, 2014 at 16:13 PM EDT
Sept 26 (Reuters) - T. Rowe Price, the second largest shareholder in Allergan Inc, said on Friday that it wants the company to hold off on making major moves before a Dec. 18 special shareholder meeting, and criticized the board's corporate governance.